THE offer for mainboard-listed prescription drugmaker Star Pharmaceutical has closed, with its executive chairman succeeding in a bid to take it private.
THE following companies saw new developments that may affect trading of their shares on Tuesday:
THE following companies saw new developments that may affect trading of their shares on Wednesday:
THE independent financial adviser (IFA) of mainboard-listed Star Pharmaceutical said on Tuesday that the offer price of S$0.45 a share is “fair and reasonable”.
THE Singapore Exchange's (SGX) minimum trading price (MTP) criteria may have claimed another victim.
The executive chairman of Mainboard-listed Star Pharmaceutical, Xu Zhi Bin, has purchased from executive director Wang Qi a 22.67 per cent stake in the pharmaceutical company for about S$1.5...